Direkt zum Inhalt
Merck

Fortfahren mit

W4262

1400W dihydrochloride

>98%, potent and selective iNOS inhibitor , solid

Synonym(e):

N-([3-(Aminomethyl)phenyl]methyl)ethanimidamide dihydrochloride

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis
10 mg
Warenkorb auf Verfügbarkeit prüfen
€ 164,00

Über diesen Artikel

Empirische Formel (Hill-System):
C10H15N3 · 2 HCl
CAS-Nummer:
Molekulargewicht:
250.17
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
>98%
Form:
solid
Storage condition:
desiccated

€ 164,00


Warenkorb auf Verfügbarkeit prüfen

​
Sonderanfertigung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Produktname

1400W dihydrochloride, >98%, solid

Quality Segment

assay

>98%

form

solid

storage condition

desiccated

originator

GlaxoSmithKline

shipped in

wet ice

storage temp.

−20°C

SMILES string

Cl[H].Cl[H].CC(=N)NCc1cccc(CN)c1

InChI

1S/C10H15N3.2ClH/c1-8(12)13-7-10-4-2-3-9(5-10)6-11;;/h2-5H,6-7,11H2,1H3,(H2,12,13);2*1H

InChI key

WDJHSQZCZGPGAA-UHFFFAOYSA-N

Gene Information

Application

1400W dihydrochloride has been used:
  • as a strong inhibitor of inducible nitric oxide to analyse its effect on intestinal ischemia/reperfusion (I/R) injury model in rat
  • as inducible nitric oxide synthase (iNOS)-selective inhibitor, to elucidate the mechanism of PM10-induced endothelial dysfunction
  • to study its efficacy on renal ischemia/ reperfusion injury in rats
  • as iNOS inhibitor to investigate its ability to counteract spatial memory deficits after hypobaric hypoxia reoxygenation

Biochem/physiol Actions

1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase (iNOS).

Features and Benefits

This compound is featured on the Nitric Oxide Synthases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
SML1314SML0893100050
description

>98%, solid

description

≥98% (HPLC)

description

≥98% (HPLC)

description

A selective, cell-permeable, irreversible, slow, tight-binding inhibitor of inducible nitric oxide synthase (iNOS; Kd = 7 nM).

assay

>98%

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥95% (HPLC)

form

solid

form

lyophilized solid

form

powder

form

solid

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

−20°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

−20°C

storage condition

desiccated

storage condition

desiccated

storage condition

desiccated

storage condition

desiccated (hygroscopic), OK to freeze

originator

GlaxoSmithKline

originator

-

originator

-

originator

-


Still not finding the right product?

Explore all of our products under 1400W dihydrochloride


Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Questions

Reviews

No rating value

Active Filters